Boston Scientific Corp (XTER:BSX)
€ 87 1.5 (1.75%) Market Cap: 126.63 Bil Enterprise Value: 134.92 Bil PE Ratio: 75.00 PB Ratio: 6.46 GF Score: 79/100

Boston Scientific Corp at Cowen Health Care Conference Transcript

Mar 13, 2019 / 12:40PM GMT
Joshua Thomas Jennings
Cowen and Company, LLC, Research Division - MD and Senior Research Analyst

Okay, guys. We're going to get started with the next session in the morning public company track. We're thrilled to have Dan Brennan, CFO; and Lindsay Fish, Director of Investor Relations, from Boston Scientific participating again this year at the Cowen Healthcare Conference. Thanks to everyone who's in the audience for joining. I'm Josh Jennings from the medical devices team, and my team is [Brian Kennedy], [Eric Henderson] and Harris Iqbal.

Well, it's great to have you guys back this year. We missed you last year, but we really appreciate you participating again, and it's great to see you guys.

Daniel J. Brennan
Boston Scientific Corporation - Executive VP & CFO

Yes. Thanks, Josh. We appreciate the invitation from Cowen, and it's a pleasure to be here.

Joshua Thomas Jennings
Cowen and Company, LLC, Research Division - MD and Senior Research Analyst

Maybe I'll just open it up, let you give a couple of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot